Dr. Jeffrey Daniel Edelson M.D.

Recommended Articles

• Atelectasis vs Pneumothorax: What’s the Difference?

  What Is Atelectasis?Atelectasis is a complete or partial collapse of the lung or lobe of a lung. This medical condition develops when the tiny sacs, known as alveoli, present within the lung become deflated.This is a breathing complication which often occurs after surgery. Apart from surgery, it is...

• Young Girl Gets ‘Game Changer’ in Fight Against Cystic Fibrosis

  At just one month old, Raelyn Copeland from Slidell, Louisiana was diagnosed with cystic fibrosis, a hereditary disorder characterized by the accumulation of mucus in the lungs that makes it difficult to breathe properly. Her mother, Angela Spencer, immediately began to advocate, campaign, and hold...

• What #break40 Means to Patients Living with Cystic Fibrosis

  2-year-old James Alexander Cargal is a bubbly and energetic little boy who enjoys singing, dancing, and playing with his dogs. But he is also a fighter. James was diagnosed with cystic fibrosis at just three weeks old. CF is a genetic disease that mostly affects the lungs, triggering persistent lung...

• Persistent and Dry Cough: What to Do?

  There are two types of cough: dry and productive. When you cough and mucus or phlegm is expelled, then it is a productive cough. A dry cough, on the other hand, can be caused by a random tickle, allergy, or dry air. There are natural remedies that can be used to relieve a cough. Home Remedies for...

• What Is Pleurisy: Get the Facts

  What is pleurisy?The pleural membrane is a very thin membrane that surrounds your lungs. It has two layers:...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...